Breast cancer, age, and hypertension: A complex issue

Hypertension

Volumn 59, Issue 2, 2012, Pages 186-188

  Ga̧sowski, Jerzy ^a   Piotrowicz, Karolina ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BEVACIZUMAB; CALCIUM CHANNEL BLOCKING AGENT; DIHIDROPRIDINE CALCIUM CHANNEL BLOCKER; DISULFIRAM; DIURETIC AGENT; REACTIVE OXYGEN METABOLITE; TAMOXIFEN; UNCLASSIFIED DRUG;

AGE DISTRIBUTION; AGING; ALCOHOLISM; APOPTOSIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CARDIOVASCULAR RISK; CAUSE OF DEATH; CELL AGING; COMORBIDITY; CYTOTOXICITY; DIABETES MELLITUS; HYPERTENSION; KIDNEY DISEASE; METASTASIS; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; VENOUS THROMBOEMBOLISM;

BREAST NEOPLASMS; FEMALE; HUMANS; HYPERTENSION;

EID: 84856287072     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.186544     Document Type: Note

References (10)

1. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, eds. SEER Cancer Statistics Review, 1975-2008. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/ 1975-2008/, based on November 2010 SEER data submission, posted to the SEER web site, 2011.
2. Hamet P, Thorin-Trescases N, Moreau P, Dumas P, Tea BS, De Blois D, Kren V, Pravenec M, Kunes J, Sun Y, Tremblay J. Workshop: excess growth and apoptosis: is hypertension a case of accelerated aging of cardiovascular cells? Hypertension. 2001;37 (2 Part 2):760-766. (Pubitemid 32199063)
3. Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324, 168 participants from randomised trials. Lancet Oncol. 2011;12:65-82.
4. Jiang X, Castelao JE, Yuan JM, Groshen S, Stern MC, Conti DV, Cortessis VK, Coetzee GA, Pike MC, Gago-Dominguez M. Hypertension, diuretics and antihypertensives in relation to bladder cancer. Carcinogenesis. 2010;31:1964-1971.
5. Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, Anton-Culver H. Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control. 2010;21:1615-1624.
6. Briones AM, Touyz RM. Oxidative stress and hypertension: current concepts. Curr Hypertens Rep. 2010;12:135-142.
7. Yip NC, Fombon IS, Liu P, Brown S, Kannappan V, Armesilla AL, Xu B, Cassidy J, Darling JL, Wang W. Disulfiram modulated ROS-MAPK and NFkappaB pathways and targeted breast cancer cells with cancer stem cell-like properties. Br J Cancer. 2011;104:1564-1574.
8. Skalska A, Ga̧sowski J, Stepniewski M, Grodzicki T. Antioxidative protection in hypertensive patients treated with diuretics. Am J Hypertens. 2005;18:1130-1132. (Pubitemid 41139914)
9. Jung SY, Rosenzweig M, Linkov F, Brufsky A, Weissfeld JL, Sereika SM. Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancer. Hypertension. 2012;59:205-211.
10. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol. 2007;50:1435-1441. (Pubitemid 47494586)